Edwards Lifesciences Corporation (NYSE:EW) went down by -3.68% from its latest closing price compared to the recent 1-year high of $131.10. The company’s stock price has collected -2.22% of loss in the last five trading sessions. Barron’s reported on 10/28/22 that Edwards Lifesciences Stock Slumps on Guidance Cut
Is It Worth Investing in Edwards Lifesciences Corporation (NYSE :EW) Right Now?
Edwards Lifesciences Corporation (NYSE:EW) scored a price-to-earnings ratio above its average ratio, recording 33.19 x from its present earnings ratio. Plus, the 36-month beta value for EW is at 1.01.
EW currently public float of 612.90M and currently shorts hold a 2.50% ratio of that float. Today, the average trading volume of EW was 5.25M shares.
EW’s Market Performance
EW stocks went down by -2.22% for the week, with a monthly jump of 3.14% and a quarterly performance of -9.08%, while its annual performance rate touched -31.55%. The volatility ratio for the week stands at 2.46% while the volatility levels for the past 30 days are set at 2.39% for Edwards Lifesciences Corporation. The simple moving average for the period of the last 20 days is 0.78% for EW stocks with a simple moving average of -15.05% for the last 200 days.
Analysts’ Opinion of EW
Many brokerage firms have already submitted their reports for EW stocks, with Stifel repeating the rating for EW by listing it as a “Hold.” The predicted price for EW in the upcoming period, according to Stifel is $75 based on the research report published on December 06th of the previous year 2022.
Mizuho gave a rating of “Buy” to EW, setting the target price at $100 in the report published on October 26th of the previous year.
EW Trading at 2.44% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -41.18% of loss for the given period.
Volatility was left at 2.39%, however, over the last 30 days, the volatility rate increased by 2.46%, as shares surge +3.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.17% upper at present.
During the last 5 trading sessions, EW fell by -2.22%, which changed the moving average for the period of 200-days by -35.93% in comparison to the 20-day moving average, which settled at $76.64. In addition, Edwards Lifesciences Corporation saw 3.35% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at EW starting from Chopra Daveen, who sale 4,000 shares at the price of $78.00 back on Jan 17. After this action, Chopra Daveen now owns 18,911 shares of Edwards Lifesciences Corporation, valued at $312,000 using the latest closing price.
MUSSALLEM MICHAEL A, the Chairman & CEO of Edwards Lifesciences Corporation, sale 19,875 shares at $78.09 during a trade that took place back on Jan 13, which means that MUSSALLEM MICHAEL A is holding 157,353 shares at $1,552,124 based on the most recent closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- +30.78 for the present operating margin
- +76.57 for the gross margin
The net margin for Edwards Lifesciences Corporation stands at +28.73. Equity return is now at value 24.50, with 17.20 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.08.